ZDHHC9 and pancreatic neoplasm: zDHHC9 silencing with nanoparticles also induced a considerable regression of pancreatic tumors and extended the survival of mice with transplantable pancreatic tumors,70 enhancing inflammation and infiltration of anti‐tumor immune effector cells and boosting anti‐PD‐L1 immunotherapy.